ISOLATION OF FUB-AMB FROM SYNTHETIC CANNABINOIDS IN HERBAL MIXTURES AT VIETNAM IN THE PERIOD OF 2016 - 2018

Nguyễn Anh Tuấn, Nguyễn Đăng Tiến

Main Article Content

Abstract

Backgrounds: Synthetic cannabinoids are currently the largest group of new psychoactive substances and one of the most recent synthetic cannabinoids that have appeared in Vietnam is FUB-AMB. In this study, the first FUB-AMB compound in Vietnam was isolated and structure determined by spectroscopic analytical methods (UV, IR, 1H-NMR, 13C-NMR). Subjects and methods:: Isolation and purity of FUB-AMB compounds used as working standard (substance). The samples of synthetic cannabinoids were collected from cases in Vietnam from 2016 to 2018, and then watered with methanol at 40°C, recovered solvent to get total methanol extract. Isolation of fractions from methanol extract by column chromatography to collect FUB-AMB. Results: FUB-AMB was collected from 10 g of total metanol extract with the purity were 98,34%. Conclusions: By chromatography methods, the compound FUB-AMB (1g) was isolated. From this result, FUB-AMB can be used as a standard substance in testing, contributing to the development of a method for analyzing narcotic drugs in the synthetic cannabinoids to support the drug  crimes handling of the authorities.

Article Details

References

1. Nghị định Sửa đổi, bổ sung Danh mục các chất ma túy và tiền chất ban hành kèm theo Nghị định số 73/2018/NĐ-CP ngày 15 tháng 5 năm 2018 của Chính phủ quy định các danh mục chất ma túy và tiền chất, 60/2020/NĐ-CP, ngày 29 tháng 5 năm 2020.
2. Ivo D. Ivanov (2019), “A case of 5f-ADB / FUB-AMB abuse: druginduced or drug-related death”, Forensic Science International, pp 372 – 377.
3. Prevention of and Fight against Crime programme (2015), “Analytical report: FUB-AMB (C21H22FN3O3)”, European Commission.
4. Samuel D. Banister (2016), “Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues”, ACS Chemical Neuroscience, pp 1241−1254
5. The New Zealand Ministry of Health (2018), AB-FUBINACA and AMB FUBINACA: Report to the Expert Advisory Committee on Drugs, pp 1 – 13.
6. World Health Organization (2018), Critical Review Report: FUB-AMB, pp 5 – 19.